Newsletter | November 29, 2022

11.29.22 -- Enhancing Bioavailability: A Science-Based Technology Selection Process

Science-Based Technology Selection For Bioavailability Enhancement

Careful selection of the right technology to enhance bioavailability and oral drug absorption is essential in development programs from initial preclinical phases to commercialization. Explore a process based on a series of inputs including the target product profile, drug properties, extensive past project experiences, technology maps, and absorption modeling.

Regulatory Services For Accelerated Development And Commercialization

The increase in Breakthrough Therapy designations and other allowances for expedited regulatory review has led to ever more innovative drug products being developed under shortened timelines. How can companies navigate today’s regulatory environment while accelerating to clinical trials and commercialization?

Project Management To Meet Today’s Drug Development Challenges

Drug development programs are becoming more complex, often spanning global networks and multiple external providers or CDMOs. Even working with a single CDMO can require coordination between production sites located on different continents. Gain insights into the steps to streamline project management to benefit small and emerging biotech companies.

Spray-Dried Dispersions Enable Local Delivery For Lung Cancer

The combination of treatment strategies used for patients suffering from advanced cases of lung cancer can cause a wide range of side effects. Spray drying is a useful particle engineering technique that can deliver particles within the necessary specifications and can be used to manufacture locally delivered dry powder inhaler treatments.

The Future Of Highly Potent API Manufacturing

Highly potent active pharmaceutical ingredients (HPAPIs) represent an increasing fraction of new compounds in pharmaceutical pipelines today. This presentation presents case studies demonstrating a range of solutions for HPAPI manufacturing, integrated drug substance and drug product development, and innovative business models.




Lonza Small Molecules shared five poster presentations at AAPS PharmSci 360. If you missed them there, they are now available in an easy-to-read online format. Visit the landing page to access the latest research from Lonza’s experts and learn more about our capabilities in drug product, particle engineering, and solid form services.